SHANGHAI, China, Jan. 20 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced the State Food and Drug Administration has approved manufacturing certificates for the production of several new products, including Synbiotics Capsules, Probiotics Gegen Capsules, Probiotics Tremella Polysaccharide Capsules and Probiotics Chewable Tablets.
"These new certificates will enable us to successfully expand our product portfolio," said Mr. Jinan Song, China-Biotics' Chairman and Chief Executive Officer. "The launch of the new products will better serve our existing customers and support our continuing regional retail expansion."
The new probiotics-based products were developed during an eight-month process and are currently in production at the Company's existing manufacturing facility.
The products are intended to offer several different health solutions to
consumers. Synbiotics Capsules' primary active ingredients are lactobacillus
thermophilus, infant bifidobacterium, bifidobacterium bifidum and oligo-
fructose, which can enhance adolescents' immune systems and gastrointestinal
("GI") health. Probiotics Gegen Capsules' primary active ingredients are
lactobacillus acidophilus and bifidobacterium bifidum ("LA-BB") and gegen
powder, a traditional Chinese medicinal herb, which can enhance women's GI
health and relieve menopausal symptoms. Probiotics Tremella Polysaccharide
Capsules' primary active ingredients are LA-BB and tremella polysaccharide,
which can enhance the GI health and immune systems of seniors. Probiotics
Chewable Tablets' primary active ingredients are lactobacillus acidophilus,
infant bifidobacterium and t
|SOURCE China-Biotics, Inc.|
Copyright©2009 PR Newswire.
All rights reserved